1. Laboratory Services
    1. Mold Services: Air
    2. Mold Services: Surface
    3. Bacteria Services: Air
    4. Bacteria Services: Surface
    5. Asbestos Services
    6. USP Services
    7. PCR Services
    8. Allergen ELISA Services
    9. Other Lab Services
    10. USP 797 Testing
    11. Legionella Water Testing
    12. ERMI Testing
    13. Materials Testing
  2. Additional Services
    1. Webinars: IAQ Training Courses
    2. Mobile App for iPhone & Android
    3. BioCassette
    4. EMLab P&K Pocket Guide
    5. Technical Papers
    6. MicroLabs
    7. MoldRANGE™ Report
    8. MoldRANGE™ California Climate Report
    9. MoldRANGE™ Local Climate Report
    10. MoldRANGE™ CFA Report
    11. MoldSCORE™ Report
    12. Risk Assessment Training Courses
  3. Quality Assurance
    1. Quality Assurance
    2. New User Introduction
    3. Become A Client
  4. Additional Information
    1. New Client Forms (pdf)
    2. Chain of Custody (pdf)
 

USP

USP 797 Count & ID 26-30C
Samples are incubated at 26º - 30º C for 5-7 days according to U.S. Pharmacopeia General Chapter 797 guidelines. Following the incubation period all colony forming units are enumerated and identified.  More details...
USP 797 Count & ID 30-35C
Samples are incubated at 30º - 35º C for 2-3 days according to U.S. Pharmacopeia General Chapter 797 guidelines. Following the incubation period all colony forming units are enumerated and identified.  More details...
USP 797-Bacteria Gloved Finger Sampling
In accordance with USP <797>, gloved fingertip samples are incubated at 30-35 degrees C for a period of 2 - 3 days. Following incubation, analysis includes enumeration of bacterial colony forming units.  More details...
USP 797-Media Fill Test
The Media Fill Test procedure is taken from U.S. Pharmacopeia General Chapter <797>. This testing is used to assess the quality of the aseptic skill of compounding personnel. The media filled containers are incubated for a minimum of 14 days at a specific incubation temperature range/s. Following incubation, Positive/Negative results are reported for visible turbidity.  More details...
USP 800 (sub-contracted) - 2 to 4 Drugs
Analysis of Bureau Veritas ChemoAlert swabs for a selection of two to four USP 800 hazardous drugs from their 10-Scan panel which includes: Cyclophosphamide, Doxorubicin & Epirubicin, Etoposide, Etoposide Phosphate, 5-Fluorouracil, Ifosfamide, Irinotecan, Methotrexate, Paclitaxol, and Vincristine.  More details...
USP 800 (sub-contracted) - 5 to 7 Drugs
Analysis of Bureau Veritas ChemoAlert swabs for a selection of five to seven USP 800 hazardous drugs from their 10-Scan panel which includes: Cyclophosphamide, Doxorubicin & Epirubicin, Etoposide, Etoposide Phosphate, 5-Fluorouracil, Ifosfamide, Irinotecan, Methotrexate, Paclitaxol, and Vincristine.  More details...
USP 800 (sub-contracted) - 8 to 10 Drugs
Analysis of Bureau Veritas ChemoAlert swabs for a selection of eight to ten USP 800 hazardous drugs from their 10-Scan panel which includes: Cyclophosphamide, Doxorubicin & Epirubicin, Etoposide, Etoposide Phosphate, 5-Fluorouracil, Ifosfamide, Irinotecan, Methotrexate, Paclitaxol, and Vincristine.  More details...
USP 800 (sub-contracted) - Single Drug
Analysis of Bureau Veritas ChemoAlert swabs for a single, selected USP 800 hazardous drug from their 10-Scan panel which includes: Cyclophosphamide, Doxorubicin & Epirubicin, Etoposide, Etoposide Phosphate, 5-Fluorouracil, Ifosfamide, Irinotecan, Methotrexate, Paclitaxol, and Vincristine.  More details...
USP 800 Platinum Drugs (sub-contracted)
Analysis of Bureau Veritas ChemoAlert swabs for total platinum, results reported as Carboplatin, Cisplatin, Oxaliplatin, or Total platinum based upon client request.  More details...